196 related articles for article (PubMed ID: 8832501)
1. The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids.
Panini R; Vandelli MA; Leo E; Salvioli G; Cameroni R
J Pharm Pharmacol; 1996 Jun; 48(6):641-4. PubMed ID: 8832501
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.
Shiotani K; Uehata K; Irie T; Uekama K; Thompson DO; Stella VJ
Pharm Res; 1995 Jan; 12(1):78-84. PubMed ID: 7724491
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro.
Nagase Y; Hirata M; Arima H; Tajiri S; Nishimoto Y; Hirayama F; Irie T; Uekama K
J Pharm Sci; 2002 Nov; 91(11):2382-9. PubMed ID: 12379923
[TBL] [Abstract][Full Text] [Related]
4. Influence of hydroxypropyl beta-cyclodextrin on the stability of benzylpenicillin in chloroacetate buffer.
Ong JK; Sunderland VB; McDonald C
J Pharm Pharmacol; 1997 Jun; 49(6):617-21. PubMed ID: 9330202
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
Celebioglu A; Uyar T
J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
[TBL] [Abstract][Full Text] [Related]
6. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
7. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben.
Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S
J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982
[TBL] [Abstract][Full Text] [Related]
8. Protective mechanism of beta-cyclodextrin for the hemolysis induced with phenothiazine neuroleptics in vitro.
Irie T; Sunada M; Otagiri M; Uekama K
J Pharmacobiodyn; 1983 Jun; 6(6):408-14. PubMed ID: 6138401
[TBL] [Abstract][Full Text] [Related]
9. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
[TBL] [Abstract][Full Text] [Related]
10. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
Yoshida A; Yamamoto M; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408
[TBL] [Abstract][Full Text] [Related]
11. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug.
Motoyama K; Nagatomo K; Abd Elazim SO; Hirayama F; Uekama K; Arima H
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1206-12. PubMed ID: 19881268
[TBL] [Abstract][Full Text] [Related]
12. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the inclusion mode of beta-cyclodextrin sulfate and its effect on the chlorpromazine-induced hemolysis of rabbit erythrocytes.
Shiotani K; Uehata K; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2332-7. PubMed ID: 7859332
[TBL] [Abstract][Full Text] [Related]
14. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone.
Lopez RF; Collett JH; Bentley MV
Int J Pharm; 2000 Apr; 200(1):127-32. PubMed ID: 10845694
[TBL] [Abstract][Full Text] [Related]
15. Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
Miyake K; Irie T; Arima H; Hirayama F; Uekama K; Hirano M; Okamaoto Y
Int J Pharm; 1999 Mar; 179(2):237-45. PubMed ID: 10053216
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
Irie T; Otagiri M; Sunada M; Uekama K; Ohtani Y; Yamada Y; Sugiyama Y
J Pharmacobiodyn; 1982 Sep; 5(9):741-4. PubMed ID: 7153847
[TBL] [Abstract][Full Text] [Related]
17. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
Abe K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
Arima H; Adachi H; Irie T; Uekama K; Pitha J
Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
[TBL] [Abstract][Full Text] [Related]
19. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.
Hirayama F; Wang Z; Uekama K
Pharm Res; 1994 Dec; 11(12):1766-70. PubMed ID: 7899242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]